← all drugs
Midazolam Hydrochloride Injection
in shortage · Anesthesia · Snapshot: 2026-10-09
Day 2,381
of this shortage, counting from the FDA's first posting on 04/02/2020
- Manufacturers listed
- Gland Pharma Limited, Hospira, Inc., a Pfizer Company, WG Critical Care, Avet Pharmaceuticals, Inc., Hikma Pharmaceuticals USA, Inc., Fresenius Kabi USA, LLC
- Reported reason(s)
- Other; Demand increase for the drug; Delay in shipping of the drug
- Machine-readable
- JSON for this drug
Presentations (27)
| Presentation | Company | Availability | Updated |
|---|---|---|---|
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 25021-655-02) | Gland Pharma Limited | Unavailable | 07/22/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-0001-25) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-610-10) | WG Critical Care | Available | 10/01/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 23155-600-41) | Avet Pharmaceuticals, Inc. | Available | 10/05/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6060-10) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-10) | Fresenius Kabi USA, LLC | Unavailable | 10/06/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6057-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-25) | Fresenius Kabi USA, LLC | Unavailable | 10/06/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 63323-412-02) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-42) | Avet Pharmaceuticals, Inc. | Available | 10/05/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6059-01) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2mL (1 mg/mL) (NDC 0409-2305-17) | Hospira, Inc., a Pfizer Company | Limited Availability | 09/22/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 2 mg/2 mL (NDC 76045-211-20) | Fresenius Kabi USA, LLC | Unavailable | 09/15/2026 |
| Midazolam Hydrochloride, Injection, 50 mg/10 mL (5 mg/mL) (NDC 0409-2596-05) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-25) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Midazolam Hydrochloride, Injection, 25 mg/5 mL (5 mg/mL) (NDC 0409-2596-03) | Hospira, Inc., a Pfizer Company | Available | 09/22/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-10) | Fresenius Kabi USA, LLC | Unavailable | 10/06/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 0641-6061-25) | Hikma Pharmaceuticals USA, Inc. | Available | 09/18/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/mL (5 mg/mL) (NDC 0409-2308-01) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Midazolam In 0.9% Sodium Chloride, Injection, 1 mg/1 mL (NDC 44567-611-10) | WG Critical Care | Available | 10/01/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-661-10) | Gland Pharma Limited | Unavailable | 07/22/2026 |
| Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 63323-411-12) | Fresenius Kabi USA, LLC | Available | 10/06/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 10 mg/2 mL (5 mg/mL) (NDC 0409-2308-02) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Midazolam Hydrochloride Preservative Free, Injection, 5 mg/5 mL (1 mg/mL) (NDC 0409-2305-05) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
| Midazolam Hydrochloride, Injection, 5 mg/1 mL (NDC 23155-601-41) | Avet Pharmaceuticals, Inc. | Available | 10/05/2026 |
| Midazolam Hydrochloride, Injection, 10 mg/10 mL (1 mg/mL) (NDC 0409-2587-05) | Hospira, Inc., a Pfizer Company | Unavailable | 09/22/2026 |
History
Daily tracking of this drug began 2026-08-25 (the first day of the archive).
- 2026-10-07 — Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-26 — Midazolam Hydrochloride Injection: availability wording revised for 2 presentation(s)
- 2026-09-24 — Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-17 — Midazolam Hydrochloride Injection: availability wording revised for 2 presentation(s)
- 2026-09-15 — Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-10 — Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-09-03 — Midazolam Hydrochloride Injection: availability wording revised for 1 presentation(s)
- 2026-08-27 — Midazolam Hydrochloride Injection: availability wording revised for 6 presentation(s)
Each daily snapshot is compared with the one before it; status changes, availability-wording revisions, and arrivals or removals are listed here. A change the FDA makes and reverses between two snapshots is not seen. Every daily record is kept in the public repository.
Not medical advice. ShortSupply republishes the FDA's drug-shortage data with history added. Talk to your pharmacist or prescriber about your situation — never change medication based on this site.